About Us       Blog       Clients       Disclaimer       Market Basics       Partners       Quotes & News       Video       Contact Us
The QualityStocks Daily Newsletter for Friday, June 26th, 2015

The QualityStocks
Daily Stock List


NuGene International, Inc. (NUGN)

SmallCapVoice reported this month on NuGene International, Inc. (NUGN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Listed on the OTC Bulletin Board, NuGene International, Inc. specializes in developing, manufacturing, and marketing proprietary regenerative cosmeceutical and pharmaceutical products. These are based on adipose derived human stem cells and human stem cell media. The Company’s goal is to take advantage of its extensive knowledge and expertise to develop age defying regenerative cosmeceutical skincare and hair care products, and also pharmaceutical products based on the same regenerative science platform. NuGene BioPharma, Inc. is the Company’s subsidiary. NuGene International has its corporate headquarters in Irvine, California.

The Company’s cosmeceutical and pharmaceutical products are based on proprietary stem cell based regenerative formulations. These are derived from non-controversial, adult human stem cell derived media obtained from adipose tissue. NuGene’s exclusive products combine its in-house advancements, proprietary technologies, as well as patent pending formulations. The Company has two patents pending covering 15 unique applications and inventions. Its products include its Skin Care Collection and its Hair Care Collection.

NuGene International’s subsidiary corporation, NuGene BioPharma has acquired all rights, title and interest in and to SkinGuardian®, a Food and Drug Administration (FDA)-approved (monographed) skin protectant, antiseptic, and moisturizing topical cream. It acquired all intellectual property (IP) held by SkinGuardian and its Founder and Owner, Chris O'Brien, relating to the SkinGuardian technology and applications.

NuGene International has filed new patents to protect proprietary claims directed to bandages treated with Human Adipose Derived Stem Cell Cultured (HADSCC) media in a variety of formats. This includes nanoencapsulated media dried to the dressings. Patent applications were filed for burn, scar and wound healing aids and bandages.

Earlier this month, NuGene International announced that it is initiating a study that will allow the Company to evaluate a medication formulation as an improved method of treating burn wounds. The study, called Comparison of an Allantoin Formulation and Allantoin Formulation with Conditioned Media of Adipose-Derived Stem Cells on Wound Healing after Ablative Fractional Carbon Dioxide Laser Resurfacing Protocol, will commence immediately. It is scheduled to run through September 1, 2015, but may be extended if needed.

This week, NuGene International announced the conclusions of an independent clinical study. The independent clinical study concludes that NuGene serum activates multiple anti-aging genes. The study was conducted by Genemarkers LLC (GM), an independent clinical laboratory equipped to analyze gene expression in the human body.

Dr. Sanjay Dhar, NuGene International's Director of Research and Development, said, "We are very excited about these significant results which indicate a more than double fold increase in multiple skin remodeling genes using our proprietary serum. These results provide essential information and important insight for future biopharmaceutical product development."

NuGene International, Inc. (NUGN), closed Friday's trading session at $3.47, up 2.66%, on 418,967 volume with 694 trades. The average volume for the last 60 days is 412,052 and the stock's 52-week low/high is $0.0086/$5.00.

OSL Holdings, Inc. (OSLH)

PennyStocks24, OtcShortReport, Pennystocktweeters.com, Winston Small Cap, Impressive Penny Stocks, OTCMagic, Real Pennies, StockMarketQuote.us, 1-2-3 Stock Alerts, Penny Stock Circle, and Fortune Stock Alerts reported earlier on OSL Holdings, Inc. (OSLH), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

OSL Holdings, Inc. is a development and technology company. It specializes in affluent, liberal markets with high disposal income. The Company’s plan is to operate a real-time loyalty rewards platform, which can facilitate the earning and redemption of rewards currency at the point of the transaction (online, mobile, at retail) and also on future transactions. OSL Holdings is a socially conscious business model committed to consumer advocacy, social activism, and the advancement of civil liberties via the power of commerce. The Company is headquartered in Yardley, Pennsylvania.

OSL Holdings has developed a multi-tier, on-line cross platform social network and information repository solution. This will permit legal marijuana dispensaries and hydroponic gardening supply retailers to manage marketing, lead generation, and retail discovery. The expectation is that the platform will become an ad supported online extension of OSL’s Go Green Hydroponics retail operations and other vertical venders. It will enable local and hyper local search with advanced querying capabilities.

The Company has its OSL Medical Services, Equality Rewards, and Shop4Equality. In 2014, OSL Holdings announced its intention to enter the legal marijuana market when federal law permits, providing foundational work for branding, marketing, technology, and logistics to existing or emerging legal marijuana licensees.

OSL Holdings has acquired Go Green Hydroponics, Inc. a privately-held hydroponics, indoor gardening, and cultivation supply retail operation, headquartered in Los Angeles, California. Go Green specializes in the sale of hydroponic cultivation equipment, mineral nutrient solutions, and gardening resources and equipment.

OSL Medical Services is a development platform concentrating on the development and financing of indoor gardens and cultivation facilities, production technologies, and merchandise and operational services for businesses in the herbal and supplement industry. The design of OSL Medical Services is to support its clients with branding, technology, marketing, logistics, and future planning services on a state-by-state basis throughout the U.S.

Equality Rewards is a platform agnostic rewards platform. Equality Rewards is currently focused on bringing minority and minority allied consumers together with businesses that support minority consumers and causes or are minority owned and operated.

Recently, OSL Holdings announced the hire of former GLAAD Chief Executive Officer (CEO) Mr. Herndon Graddick as Chief Marketing and Policy Officer.  Mr. Graddick is the former CEO and President of GLAAD, the world's largest media advocacy organization for the LGBT community.

OSL Holdings, Inc. (OSLH), closed Friday's trading session at $0.00191, down 7.73%, on 16,293,858 volume with 53 trades. The average volume for the last 60 days is 27,129,594 and the stock's 52-week low/high is $0.001/$0.054.

FluoroPharma Medical, Inc. (FPMI)

INO.com Market Report and TaglichBrothers reported earlier on FluoroPharma Medical, Inc. (FPMI), and today we report on the Company, here at the QualityStocks Daily Newsletter.

FluoroPharma Medical, Inc. specializes in the development of novel diagnostic imaging products that use Positron Emission Tomography (PET) technology for the detection and assessment of disease before clinical manifestation. The Company is a biopharmaceutical entity involved in the discovery and development of proprietary PET imaging products to evaluate cardiac disease at the cellular and molecular levels. FluoroPharma Medical has licensed technology from the Massachusetts General Hospital in Boston, Massachusetts. The OTCQB-listed Company has its headquarters in Montclair, New Jersey.

Patents related to FluoroPharma Medical’s portfolio of imaging compounds have been issued in the United States, Europe, China, Japan, Canada, Australia, and Mexico. The Company’s initial emphasis is the development of innovative PET imaging agents. It is advancing two products in clinical trials for assessment of acute and chronic forms of coronary artery disease.

The design of these first in class agents is to target, quickly, myocardial cells. Other products in development include agents for the detection of inflamed atherosclerotic plaque in peripheral arteries, agents with the potential to image Alzheimer's disease, and agents that could potentially be used for imaging specific cancers.

CardioPET™ is one of FluoroPharma's first in class PET imaging products. CardioPET™ is a perfusion and fatty acid uptake indicator. The design of it is for use as a cardiac imaging agent. It may be a more specific alternative to currently available diagnostic tests.

FluoroPharma Management believes its pharmacokinetic characteristics could be especially valuable in patients who are unable to exercise. FluoroPharma Medical announced in December 2014 scheduled completion of enrollment in a Phase II Clinical Trial of CardioPET™ (18F FCPHA) for Assessment of Coronary Artery Disease (CAD).

In addition, FluoroPharma has its BFPET PET Scan Imaging Agent. BFPET is a Flourine-18 labeled tracer. The design of it is to enter the myocardial cells in direct proportion to blood flow and cell membrane potential. These are two of the most important physiological indicators upon which suitable blood supply to the heart depends. The design of BFPET has been to differentiate among those cells of the myocardium, which may be ischemic, infarcted and those that are healthy.

FluoroPharma Medical, Inc. (FPMI), closed Friday's trading session at $0.40, up 1.27%, on 44,139 volume with 13 trades. The average volume for the last 60 days is 35,423 and the stock's 52-week low/high is $0.2134/$0.73.

3DX Industries, Inc. (DDDX)

Wealth Daily and Real Pennies reported previously on 3DX Industries, Inc. (DDDX), and we are highlighting the Company today, here at the QualityStocks Daily Newsletter.

3DX Industries, Inc. concentrates on the additive metal manufacturing segment within the aerospace, energy, medical and manufacturing industries. The Company can manufacture a broad array of products employing its three-dimensional (3D) metal printing system, 3D composite printing, and many CNC Precision Machining Centers.  3DX Industries has its corporate headquarters in Ferndale, Washington.

3DX Industries offers additive and traditional manufacturing services as well as product design, engineering, and assembly services to its customers. In May 2014, the Company announced that it completed its first series of production run components using the M-Flex™ Metal Printing System manufactured by The ExOne Company. ExOne is an international provider of 3D printing machines and printed products to industrial customers.

3DX Industries has printed numerous 3D Metal components and parts for clients’ use. It continues to produce 3D metal printed parts using the M-Flex™ Metal Printing System manufactured by ExOne.

3DX's M-Flex™ metal printing system from ExOne employs an additive manufacturing process. This is known as three-dimensional printing, or 3DP. It materializes an object—or mold for an object—layer by layer out of powdered material, a chemical binder and a digital file. The process is also called Binder Jetting Technology.

With 3D Metal Printing, 3DX Industries helps its customers save material cost and weight for prototyping and short run productions. It can make a customer’s proto-type or production run items efficiently, cost effectively, and on time using the latest 3D Metal printing technology with 3DX’s M-Flex 3D Metal printer, its Z-Corp Composite Printer or through its in-house precision machine shop. 3DX Industries continues to build on its additive manufacturing capabilities as it produces prototypes for its growing customer base.

In December 2014, 3DX Industries announced that it entered into an agreement with Baklund R&D of Hutchinson, Minnesota to create FDM/BJT hybrids. The agreement focuses around project collaboration relating to FDM (Fused Deposition Modeling) and Binder Jet Additive Technologies (BJT), where 3DX Industries will provide 3D metal printing support to Baklund. Baklund will provide advanced composite printing support to 3DX Industries.

3DX Industries, Inc. (DDDX), closed Friday's trading session at $0.025, even for the day, on 24,149 volume with 6 trades. The average volume for the last 60 days is 27,156 and the stock's 52-week low/high is $0.0125/$1.18.


Today we are reporting on CDEX, Inc. (CDEX), here at the QualityStocks Daily Newsletter.

OTCQB-listed CDEX, Inc. is an innovative developer, manufacturer, and distributor of patented, real-time chemical detection and validation technologies for the healthcare and security markets. The Company’s proprietary solutions are based on its patented Enhanced Photoemission Spectroscopy technology for substance verification, authentication, and identification. CDEX is based in Tucson, Arizona.

The Company’s solutions include the ValiMed™ Medication Validation System product line. This is marketed to healthcare markets around the world for use in combatting diversion of controlled substances and narcotics. Its solutions also include compounded liquid pharmaceuticals to help ensure patient safety, and the ID²™ product line marketed to the worldwide security market for use in detecting illegal or illicit drugs in difficult-to-monitor, critical environments. 

ValiMed™ validates high-risk medications before leaving the pharmacy. In addition, it monitors and discourages the diversion of controlled substances through validating the returned (unused) narcotics from patient treatment areas and surgery suites. The ValiMed™ Medication Validation System detects human mishaps, considerably raising the bar on medication safety and pharmaceutical drug loss prevention.

The ValiMed G4 drug validation system helps healthcare providers ensure patient safety and control costs through lessening medication errors. CDEX’s G4 device will assist healthcare facilities in complying with Joint Commission compliance requirements and USP 797 guidelines for compounding sterile preparations (CSPs) and integrate with electronic medical record (EMR) platforms.

Concerning the ID² Meth Scanner, it is a hand-held, battery-operated methamphetamine detector. The same advanced technology used in ValiMed™ is applied to detect trace quantities (low nanogram range) of meth in real time, without the risk of harmful contact through skin absorption or inhalation from testing. The ID² Meth Scanner is calibrated for precision measuring and convenient operation in detecting trace amounts of methamphetamines.

This past April, CDEX announced that the United States Patent and Trademark Office (USPTO) granted the Company U.S. Patent 9,013,686 B2, relating to the methods for identification and determination of unknown substances using Enhanced Photoemission Spectroscopy.

Mr. Jeffrey Brumfield, Chairman and Chief Executive Officer of CDEX, stated, "This newly issued patent demonstrates our continuous efforts to remain on the forefront of innovation within the industry. Moreover, it validates the ValiMed™ System's capabilities to identify specific molecules in a substance and determine their concentration in both single and multiple-substance mixtures.”

CDEX, Inc. (CDEX), closed Friday's trading session at $0.0452, down 9.60%, on 27,267 volume with 6 trades. The average volume for the last 60 days is 9,247 and the stock's 52-week low/high is $0.0111/$0.10.


The QualityStocks
Company Corner


Dominovas Energy Corp. (DNRG)

The QualityStocks Daily Newsletter would like to spotlight Dominovas Energy Corp. (DNRG). Today, Dominovas Energy Corp. closed trading at $0.1139, on 37,132,028 volume with 4,028 trades. The stock’s average daily volume over the past 60 days is 2,813,875 and its 52-week low/high is $0.0035/$0.45.

Dominovas Energy Corp. announced earlier this week it has landed a new partnership with the United States government. Specifically, Dominovas Energy Corporation has been named as the first, and only, fuel cell company selected as a Private Sector Partner to President Barack Obama's POWER AFRICA INITIATIVE. Dominovas Energy's President of its Africa Division, Emilio De Jesus, added, "With Power Africa's commitment to the entire sub-Saharan Africa, it has set the stage for Dominovas Energy to complete sales cycles it began in earnest over two years ago with government officials of respective nations working closely with our company to realize a viable solution to their energy sector concerns."

Dominovas Energy Corp. (DNRG) is an energy solutions company dedicated to bringing clean, sensible and reliable power to areas of the world that lack this precious commodity. Recognizing the incredible growth and profit opportunities of the green and alternative energy markets, Dominovas Energy defined a sustainable deployment model to take a leading position among alternative green energy solutions providers.

At the heart of Dominovas Energy’s Fuel Cell Division is a revolutionary energy solution powered by the RUBICON™ Series Solid Oxide Fuel Cell (SOFC) Technology. Invented by inventor, scholar, professor and visionary Dr. Shamiul Islam, RUBICON™ achieves more than 50% fuel-to-electricity efficiency, providing cost effective, clean, significantly-reduced emissions with silent operations in 100kW to multi-megawatt power arrays. The proprietary system is capable of reforming and converting multiple fuel stocks, and is expected to become the “PLATINUM Standard” by which all other fuel cell technologies are measured.

In early 2014, Dominovas Energy was acquired by Western Standard Energy Corp. in a merger transaction in which Dominovas Energy was the emerging entity. Per the acquisition, Dominovas Energy obtained Western Standard’s 49.25% ownership of award-winning renewable energy company Pro Eco Energy Ltd. Pro Eco Energy provides award-winning heating and cooling systems for commercial and public buildings, delivering the newest alternative energy technologies for energy efficient HVAC systems in a timely and cost-competitive manner.

Dominovas Energy intends to build and own fuel cell utilities worldwide, joining the ranks of some of the world’s largest and most well-known companies that are already taking advantage of the vast opportunities of fuel cell systems. The RUBICON™ is far superior to any other system on the market today, and Dominovas Energy’s ability to produce a fuel cell that accepts multiple fuel sources is invaluable to meet the demands of the mass market. Disclaimer

Dominovas Energy Corp. Blog

Dominovas Energy Corp. News:

Dominovas Energy Lauds Scope of Power Africa Initiative

Dominovas Energy Lands Historic Partnership With U.S. Government

Dominovas Energy Enters Second Power Provider Agreement in the Democratic Republic of the Congo

One World Holdings, Inc. (OWOO)

The QualityStocks Daily Newsletter would like to spotlight One World Holdings, Inc. (OWOO). Today, One World Holdings, Inc. closed trading at $0.007, up 25.00%, on 9,913,831 volume with 176 trades. The stock’s average daily volume over the past 60 days is 7,664,311, and its 52-week low/high is $0.0008/$0.05.

One World Holdings, Inc. (OWOO) subsidiary, The One World Doll Project, was established in 2010 to make a significant positive cultural impact through the doll category, transcending global and ethnic borders to create positive self-image in young women and girl around the world. Led by worldwide famous doll designer Stacy McBride-Irby, The One World Doll Project team has more than 50 collective years in the doll and toy industry and is dedicated and armed with the experience to ensure that the dolls are of the highest quality and value.

In 2013, the company released its Prettie Girls!™ line of multi-cultural fashion dolls uniquely designed with individual physical attributes, personal stories and hobbies, and goals and inspirations. For young girls, the dolls are a friend, a partner in play, and a glimpse of their biggest, brightest dreams. For young women, the dolls are a symbol of who they are and what they can achieve. For doll connoisseurs, The One World Doll Project promises stylish works of art that will become a vital part of a growing collectors’ market.

The One World Doll Project also has a Signature Celebrity Collection of Prettie Girls! and in 2013 released its first celebrity collectors doll modeled after supermodel Cynthia Bailey from The Real Housewives of Atlanta. Since the release of the doll, it has been showcased with Synthia on The Arsenio Hall Show, What Happens Live with Andy Cohen and The Bethenny Show.

Using a web-based sales model, One World Holdings plans to quickly capture significant market share in the dolls and stuffed toys space. After securing a strong online presence, the company will focus on brick and mortar retailing as it moves toward the ultimate pursuit of expanding worldwide. The company has established distribution deals with Toys “R” Us, HEB, dollgenie.com, Tuckers Toy Shop, pattycakedoll.com, and has recently expanded its retail presence internationally with the People’s Pharmacy storechain in the Central American country of Belize. The Prettie Girls! Dolls have been featured in national and international media spotlights like CNN, The Wall Street Journal, Jet Magazine, Bloomberg.com, Parade.com, Dolls Magazine, The Toy Book, The Houston Chronicle and Houston Business Journal, and TheStreet.com. Disclaimer

One World Holdings, Inc. Company Blog

One World Holdings, Inc. News:

Based on Prettie Girls! Dolls Retail Success; Tonner Doll Company to Acquire Equity Stake in One World Holdings, Inc.

The One World Doll Project to Give Updates on National Wal-Mart Roll Out and Business Expansion Plans on Quarterly Conference

Fortune Article Highlights The One World Doll Project's Retail Success

Well Power Inc. (WPWR)

The QualityStocks Daily Newsletter would like to spotlight Well Power Inc. (WPWR). Today, Well Power Inc. closed trading at $0.0007, up 16.67%, on 41,462,301 volume with 95 trades. The stock’s average daily volume over the past 60 days is 13,556,300, and its 52-week low/high is $0.0003/$0.1395.

Well Power Inc. (WPWR) has secured the licensing rights to Texas with the first right of refusal on the other US states to a new technology solution to process waste natural gas, such as vented, flared or stranded gas, into “clean power” and engineered fuels, including no-sulphur diesel and diluents. Based on proprietary technology, this solution is mobile, high-yield and can be deployed with minimum capital expenditure.

The company plans to be able to provide its technology with full-service engineering, design, construction, modular fabrication, maintenance and construction management services to clients in the upstream areas of exploration and production. Well Power will also offer consulting services, process assessments, facility appraisals, feasibility studies, technology evaluations, project finance structuring and support, and multi-client subscription services.

Approximately 2.4 million barrels of oil equivalent is wasted each day by gas flaring alone, resulting in $10 billion of lost revenue and 400 million metric tons of CO2 equivalent global greenhouse gas emissions each year. Additionally, environmental degradation associated with gas flaring has been shown to have a significant impact on local populations, often resulting in loss of livelihood and severe health issues.

Well Power’s Micro Refinery Unit (MRU) offers the opportunity to create value from a wasted resource while simultaneously enabling wider access to energy, improved environmental conditions, and economic development for local populations. By eliminating legacy flaring and minimizing new flaring, the company is well positioned to take a leadership role in the ongoing push for sustainable resource development and energy efficiency. Disclaimer

Well Power Inc. Company Blog

Well Power Inc. News:

Well Power Inc. Appoints Professional Engineer, Oil & Gas Veteran to Board of Directors

Well Power - Letter from President to Shareholders

Well Power Inc. to host second webinar on proprietory micro-refinery technology

MIT Holding (MITD)

The QualityStocks Daily Newsletter would like to spotlight MIT Holding (MITD). Today, MIT Holding closed trading at $0.036, up 20.00%, on 1,150 volume with 1 trade. The stock’s average daily volume over the past 60 days is 8,419, and its 52-week low/high is $0.03/$0.29.

MIT Holding (MITD), through its agents, facilitators and contractual obligations, offers professional outpatient medical care with ambulatory infusion therapies, home infusion services, and medical equipment delivery. The company is also pursuing government contacts to obtain approval to import pharmaceutical products into the Americas.

In support of these core services, MIT Holding provides expert legal, accounting, advisory and educational services to physicians, medical centers, hospitals, small and large businesses regarding the Affordable Care Act; offers travel and transportation services of medically challenged patients for medical needs and personal travel; and through its contracts is approved to, conduct and administer FDA clinical trials.

Collectively, these services contribute to MIT Holding’s strategy to provide custom prescription solutions in a variety of methods and generate multiple revenue streams. Following a successful reorganization initiative in January, 2014, MIT Holding is positioned to achieve 32% minimum net profits and has maintained profitability in its fiscal second and third quarters. This profitability validates the company’s business model and its approach to the evolving Affordable Health Care Act and its impact on the health services industry.

MIT Holding meets and/or exceeds major U.S. health insurance requirements and is therefore able to direct bill and receive payments from carriers on behalf of the patient its agents and its facilitators. This ability marks an important step in the company’s goal of developing the first-of-its-kind seamless transition for patient needs from hospital discharge to complete home recovery. This and other corporate initiatives are spearheaded by a management team committed to building shareholder value, revenues and corporate expansion while providing viable solutions to the perpetual changes in the health care sector. Disclaimer

MIT Holding Company Blog

MIT Holding News:

MIT Holding Achieves Positive Net Income From Operations in 2014

MIT Holding (MITD) Launches New Website with Investor Relations Suite

MIT Holding, Inc. Names Tommy J. Duncan as President

Galenfeha, Inc. (GLFH)

The QualityStocks Daily Newsletter would like to spotlight Galenfeha, Inc. (GLFH). Today, Galenfeha, Inc. closed trading at $0.43, up 7.50%, on 140,881 volume with 45 trades. The stock’s average daily volume over the past 60 days is 36,014, and its 52-week low/high is $0.1011/$4.00.

Galenfeha, Inc. (GLFH) is an engineering, product development, and manufacturing company that provides innovative solutions for oil and natural gas production, as well as stored energy products across a number of different industries. The company provides these products and services through its stored energy and oil & gas division.

Through its stored energy division, Galenfeha offers one of the most powerful, environmentally friendly battery systems in the market. The batteries have onboard computers, are inherently safe, internally temperature regulated, have optional GPS monitoring capabilities, offer significant weight reduction of up to 50%, and are engineered specifically for each type of application. Features include 100% “green” chemistry, RoHS compliancy, and active short circuit protection control.

Through its oil and gas division, the company offers chemical injection pumps that merge the perceived benefits of a hybrid, electric over pneumatic system. Galenfeha management believes the combination of the two parameter control systems represents a measurable shift in efficiency, reliability, cost management, and profitability to individual well locations as well as entire production fields. The combined technologies have demonstrated increased chemical injection accuracy, reducing chemical contamination in the production process while controlling cost and waste.

The company’s unwavering dedication is to continuously develop products that perform better than conventional solutions while also reducing environmental impact. Leveraging the management team’s wealth of resources and relationships, Galenfeha is well positioned for continued growth as the company aims to expand in both the stored energy and oil & gas industries. Disclaimer

Galenfeha, Inc. Company Blog

Galenfeha, Inc. News:

Galenfeha Stored Energy Solutions Enters Aviation Industry

Galenfeha Broadens Oil and Gas Industry Penetration

Lithium Iron Phosphate Battery Tech: Providing Better Performance and Environmental Sustainability


Rate Us
Tell us how we're doing!
Click here to begin your review.

Today's Top 3
Investment Newsletters








By The Numbers Charts

The QualityStocks Public Company Sponsor News

Featured Sponsor

Daily Sponsors


The QualityStocks By The Numbers Report

Click the chart below to see the full report

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market
each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge"
based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.


About Us     Archives     Blog     Clients     Disclaimer     Market Basics    Partners      Quotes & News     Video     Contact Us

twitter icon facebook icon

QualityStocks Logo

Copyright © 2006 - 2012. QualityStocks 3370 N. Hayden Rd., Suite 123-591, Scottsdale, AZ 85251